Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness

In Italy, a sequential pneumococcal vaccination with conjugate vaccine (PCV) and polysaccharide vaccine (PPSV23) is recommended for individuals aged ≥ 65 years and those at risk for pneumococcal disease (PD) aged ≥ 6 years. The aim of this study was to assess the cost-effectiveness of the new vaccin...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Vincenzo Restivo, Vincenzo Baldo, Laura Sticchi, Francesca Senese, Gian Marco Prandi, Linde Pronk, Kwame Owusu-Edusei, Kelly D. Johnson, Tim Ignacio
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	cost-effectiveness models pneumococcal disease sequential vaccination Italy non-bacteremic pneumococcal pneumonia geometric mean titer
Online Access:	https://www.mdpi.com/2076-393X/11/7/1253